Macter International Limited (PSX:MACTER)

Market Cap	13.33B -10.0%
Revenue (ttm)	11.58B +24.4%
Net Income	815.46M +35.2%
EPS	17.80 +35.7%
Shares Out	45.81M
PE Ratio	16.35
Forward PE	n/a
Dividend	3.80 (1.31%)
Ex-Dividend Date	Oct 16, 2025

Volume	4,396
Average Volume	15,338
Open	297.99
Previous Close	291.62
Day's Range	290.00 - 297.99
52-Week Range	255.10 - 621.82
Beta	0.07
RSI	43.99
Earnings Date	May 15, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1992
• Employees: 1,282
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: MACTER

Financial Performance

In fiscal year 2025, Macter International's revenue was 10.36 billion, an increase of 29.91% compared to the previous year's 7.97 billion. Earnings were 776.43 million, an increase of 90.91%.